Type 1 diabetes



Vertex Acquires Semma Therapeutics for $950M to Develop Treatments for Type 1 Diabetes

Vertex Pharmaceuticals announced earlier this week that it will acquire Semma Therapeutics, a privately held biotechnology company working on a …


Implantable ‘Tea Bag’ in Development Releases Insulin for Children with Diabetes

Republished with permission from The University of Arizona. Children with Type 1 diabetes have only one option to control their blood sugar: insulin …

| |

JDRF Launches New Center To Accelerate Breakthroughs in Type 1 Diabetes Cures

JDRF, an organization funding Type 1 diabetes research, today announced the launch of the JDRF Northern California Center of Excellence. The new …